Tumia Rima, Wang Chao J, Dong Tianhan, Ma Shijie, Beebe Jenny, Chen Juan, Dong Zizheng, Liu Jing-Yuan, Zhang Jian-Ting
Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN, United States.
Department of Cancer Biology, University of Toledo College of Medicine and Life Sciences, Toledo, OH, United States.
Front Cell Dev Biol. 2020 Aug 19;8:753. doi: 10.3389/fcell.2020.00753. eCollection 2020.
Translation initiation in protein synthesis regulated by eukaryotic initiation factors (eIFs) is a crucial step in controlling gene expression. eIF3a has been shown to regulate protein synthesis and cellular response to treatments by anticancer agents including cisplatin by regulating nucleotide excision repair. In this study, we tested the hypothesis that eIF3a regulates the synthesis of proteins important for the repair of double-strand DNA breaks induced by ionizing radiation (IR). We found that eIF3a upregulation sensitized cellular response to IR while its downregulation caused resistance to IR. eIF3a increases IR-induced DNA damages and decreases non-homologous end joining (NHEJ) activity by suppressing the synthesis of NHEJ repair proteins. Furthermore, analysis of existing patient database shows that eIF3a expression associates with better overall survival of breast, gastric, lung, and ovarian cancer patients. These findings together suggest that eIF3a plays an important role in cellular response to DNA-damaging treatments by regulating the synthesis of DNA repair proteins and, thus, eIIF3a likely contributes to the outcome of cancer patients treated with DNA-damaging strategies including IR.
由真核生物起始因子(eIFs)调控的蛋白质合成起始是控制基因表达的关键步骤。已有研究表明,eIF3a通过调节核苷酸切除修复来调控蛋白质合成以及细胞对包括顺铂在内的抗癌药物治疗的反应。在本研究中,我们验证了这样一个假设:eIF3a调控对电离辐射(IR)诱导的双链DNA断裂进行修复的重要蛋白质的合成。我们发现,eIF3a的上调使细胞对IR敏感,而其下调则导致细胞对IR产生抗性。eIF3a通过抑制非同源末端连接(NHEJ)修复蛋白的合成,增加了IR诱导的DNA损伤并降低了NHEJ活性。此外,对现有患者数据库的分析表明,eIF3a的表达与乳腺癌、胃癌、肺癌和卵巢癌患者更好的总生存率相关。这些发现共同表明,eIF3a通过调节DNA修复蛋白的合成,在细胞对DNA损伤治疗的反应中发挥重要作用,因此,eIF3a可能影响采用包括IR在内的DNA损伤策略治疗的癌症患者的预后。